Erich Mounce, chief operating officer, OneOncology, discusses how payment models like the Oncology Care Model are changing the way oncologists practice, as well as what practices should prioritize when looking to participate in a payment model.
Erich Mounce, chief operating officer, OneOncology, discusses how payment models like the Oncology Care Model are changing the way oncologists practice, as well as what practices should prioritize when looking to participate in a payment model.
Transcript
How are payment models, such as the Oncology Care Model, changing the way community oncologists practice?
I think for the better. From my perspective, that standardization of payment models is allowing us to drive the same kind of care based on evidence. For example, it send to be that medical oncologists could only use 1 or 2 drugs in their tool chest. Not all of those drugs would work on those cancers, but they’d use them anyway because there was a 50/50 chance or a 60/40 chance that they would work. Now, with targeted medicine, that allows us to target the right drugs and then allows us to really work on value-based care, Oncology Care Model standardization to use a care model that processes through with the patient’s care.
It’s not just a regimen. For us at OneOncology, a care pathway or a care model that goes within a bundled payment or Oncology Payment Model is also really soup to nuts. It is, once you’re diagnosed, when do you see a genetic counselor? When do you see the surgeon? When do you get the CT [computerized tomography] scan? When do you get the PET [positron emission tomography] scan? When do you have surgery? When do you have chemo? It’s not just what drugs are used, and for me, that’s really a challenging step that gives a lot of opportunity to be successful with patient care in the future.
When looking to participate in a payment model, what should practices prioritize?
There’s lots of variations out there. The most important thing is to find a model that’s passionate about patient care and about the delivery of that care, not just commoditizing drug prices or supply prices. It’s really about making sure you have somebody that believes the same way that a physician did when they went to school and now that they’re a medical oncologist about how to treat the patient right and everything else follows that.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More